Abbott Laboratories
ABT
|
|
|
|
Trading Volume | 108,410 |
|
120.98 - 90.20 |
Market Cap Full | $ 195.8B |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 0.6% | 3.2% | -7.8% | -15.9% |
Q2 | - | -6.7% | 7.6% | -8.2% |
Q3 | - | 6.5% | -11.2% | -11.4% |
Q4 | - | -1.6% | 15% | 14% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
0.6 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
2.8 | 4.8 | -4.1 | -5.6 | -4.7 | 2.3 | 1.3 | 6.5 | - | - | - | - |
2023 | |||||||||||
0.7 | -8 | -0.4 | 9.1 | -7.7 | 6.9 | 2.1 | -7.6 | -5.9 | -2.4 | 10.3 | 5.6 |
2022 | |||||||||||
-9.4 | -5.4 | -1.9 | -4.1 | 2.3 | -6.4 | 0.2 | -5.7 | -6.2 | 2.7 | 8.7 | 2.1 |
2021 | |||||||||||
12.9 | -3.1 | 0.1 | -0.3 | -2.3 | -0.6 | 4.4 | 4.5 | -6.5 | 9.1 | -1.5 | 10.8 |
2020 | |||||||||||
2.8 | -15.3 | 4.9 | 16.7 | 3.1 | -3.7 | 10.1 | 8.8 | -0.6 | -4.5 | 4.1 | 1.2 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | 0.8 | 1.4 | 1 | 0.3 |
Q2 | 0.8 | 1.1 | 0.7 | 0.3 |
Q3 | 0.8 | 0.8 | 1.2 | 0.7 |
Q4 | 0 | 0.6 | 1.1 | 1.2 |
A | 2.35 | 3.9 | 3.9 | 2.5 |